>亚太地区 Pingueculum 药物市场，按治疗方法（人工泪液/外用润滑剂、类固醇眼药水、非甾体抗炎滴剂等）、配方类型（眼药水、眼膏等）、购买方式（处方药、非处方药 (OTC)）、药品类型（品牌药和仿制药）、人群类型（老年人和成人）、最终用户（医院、专科诊所、家庭医疗保健等）、分销渠道（医院药房、零售药房、网上药房等）划分 - 行业趋势和预测到 2029 年。
亚太地区 Pingueculum 药物市场分析与洞察
结膜黄斑是典型的非恶性结膜增生，其危险因素包括紫外线照射、创伤、风沙、长期户外工作和年龄增长。
亚太地区 pingueculum 药物市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响、市场中的地理扩张和技术创新的详细信息。要了解分析和市场情况，请联系我们获取分析师简报。我们的团队将帮助您创建收入影响解决方案，以实现您的预期目标。
Data Bridge Market Research 分析称，2022 年至 2029 年的预测期内，亚太地区栓塞药物市场将以 8.5% 的复合年增长率增长。
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020 (定制至 2014-2019) |
|
定量单位 |
收入（百万美元），定价（美元） |
|
涵盖的领域 |
按治疗（人工泪液/局部润滑剂、类固醇眼药水、非甾体抗炎滴剂等）、配方类型（眼药水、眼膏等）、购买方式（处方药、非处方药 (OTC)）、药品类型（品牌药和仿制药）、人群类型（老年人和成年人）、最终用户（医院、专科诊所、家庭医疗保健等）、分销渠道（医院药房、零售药房、网上药房等） |
|
覆盖国家 |
中国、日本、韩国、印度、澳大利亚、新加坡、泰国、马来西亚、印度尼西亚、菲律宾、越南和亚太地区其他地区 |
|
涵盖的市场参与者 |
AbbVie Inc.、Amneal Pharmaceuticals LLC.、Spectra Vision Care、SAGER PHARMA、Maya Biotech Private Limited、诺华公司、Akorn Operating Company LLC、Théa Laboratories、OASIS Medical、Similasan Corporation、Bausch & Lomb Incorporated、Prestige Consumer Healthcare, Inc.、Alcon Inc.、Wellona Pharma、强生视力保健公司、EYERIS VISIONCARE Pvt. Ltd.、Sylentis、Zydus Group、拜耳公司、参天制药株式会社 |
市场定义
结节性黄斑是一种典型的非恶性结膜增生。这是一种透明、脆弱的组织，环绕着眼白区域（巩膜）。结节性黄斑一词源于拉丁语 pinguis，意为“脂肪”或“油脂”。这种增生发生在眼睛睁开时暴露在外的结膜部分。结节性黄斑的危险因素包括暴露于紫外线、创伤、风、灰尘和沙子、长时间在户外工作和年龄增长。有过高紫外线暴露史的人和居住在赤道附近的人发病率更高（户外工作）。根据某些研究，男性的发病率略高于女性，这可能只是因为男性的紫外线暴露率更高。它看起来像结膜上靠近角膜的一个微小的黄色肿块。它可能出现在角膜的两侧。
亚太地区 Pingueculum 药物市场动态
本节旨在了解市场驱动因素、优势、机遇、限制和挑战。下文将详细讨论所有这些内容
- 翼状胬肉疾病和眼痛患病率不断上升
2020年，根据ULAKBİM Journal Systems发表的文章《土耳其西部翼状胬肉的流行情况及相关因素》，研究对象为土耳其西部1443名20岁以上的人群，结果发现52.5%的人患有翼状胬肉，而且在这52.5%的人中，男性翼状胬肉的患病率（58.4%）高于女性（46.8%）。
由于全球范围内多种环境和外部因素的影响，翼状胬肉病的患病率持续呈激增趋势。化学灼伤和闪光灼伤会因眼表受到刺激而导致严重而剧烈的眼部疼痛。因此，翼状胬肉病和眼部疼痛患病率的上升预计将在预测期内推动亚太地区翼状胬肉药物市场的发展。
- 臭氧缺陷导致慢性紫外线照射增加
2019年，根据“视觉与眼科学研究协会”发表的期刊，发现早期翼状胬肉在颞部结膜的患病率为39.5%，在鼻部结膜的患病率为43.9%。报告的户外活动时间分别为19.6%和16.1%（少于2小时）、44.7%和52.2%（4至6小时）、75.0%（两者均超过6小时），这表明翼状胬肉的患病率与户外活动时间和紫外线照射呈正相关。
暴露于紫外线越多，患上翼状胬肉的几率就越高。这表明翼状胬肉的患病率与暴露于阳光之间存在联系。臭氧层缺陷也导致暴露于紫外线越多，从而增加了翼状胬肉疾病的患病率。因此，预计这将推动亚太地区翼状胬肉药物市场的增长。
- 降低眼疾患病率的举措和计划
2020年，瑞士日内瓦世界卫生组织 (WHO) 和英国伦敦国际防盲机构 (IAPB) 于 1999 年发起了“视觉 2020：看得见的权利”倡议。欧洲倡议“视觉 2020”旨在到 2020 年消除可避免的失明，并重点关注可避免的视力障碍的主要原因。
根据CDC（疾病控制和预防中心）的文章，2022年，CDC通过视力健康倡议（VHI）和各利益相关方启动了一个协调的国家公共卫生框架，以预防失明和视力障碍。
这些举措和计划为市场带来了机遇。因此，减少眼病发病率的举措和计划有望成为亚太地区眼睑黄斑变性药物市场增长的机遇。
限制/挑战
- 类固醇眼药水的副作用
轻度至重度睑裂斑患者建议眼科医生或验光师进行全面检查并及时治疗。最常见的是使用局部热带类固醇、热带免疫调节剂、润滑软膏、凝胶或滴剂来治疗。
泼尼松龙是治疗眼部疼痛最常用的局部类固醇。醋酸泼尼松龙眼用混悬液具有以下常见不良反应：
- 使用此药后，眼睛会刺痛、灼伤或发痒一至两分钟
- 视线暂时模糊
- 增强光敏感度
- 视觉改变
- 眼睛里有异物
- 过敏反应
缺乏眼科治疗医疗设施
根据 IntechOpen 2020 报告，高收入国家失明和眼部疾病的患病率为每 1000 人 0.3 人，但低收入国家估计为每 1000 人 1.5 人。这表明低收入国家对眼科护理的需求尚未得到满足
低收入国家的另一个主要问题是缺乏对眼痛和其他疾病的认识。许多研究报告称，低收入国家对眼保健的需求很高，其未满足的需求仍然受到许多医疗机构的关注。因此，中低收入国家较差的眼科治疗医疗设施可能会成为亚太地区眼睑板腺药物市场增长的制约因素。
新冠肺炎疫情对亚太地区 Pingueculum 药物市场的影响
COVID-19 给市场带来了负面影响。疫情期间的封锁和隔离使疾病管理和服药依从性变得复杂。无法到医疗机构进行常规治疗和服药将进一步影响市场。
近期发展
- 2022 年 5 月，爱尔康宣布收购 Kala Pharmaceuticals, Inc. 旗下的 EYSUVIS（洛替泼诺依碳酸酯混悬液）眼药水。此次收购将补充该公司的 Systane 系列眼药水，其中包括不含防腐剂的配方等
- 2022 年 9 月，强生视力保健公司宣布推出其新创新产品 Acuvue Oasys Max 日用隐形眼镜和老花眼多焦点隐形眼镜。此外，这些新隐形眼镜采用新技术，以满足数字密集型生活方式的需求
亚太地区 Pingueculum 药物市场范围
亚太地区 pingueculum 药物市场根据药物类型、治疗、配方、购买方式、人群类型、最终用户和分销渠道分为七个值得注意的细分市场。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。
治疗
- 人工泪液/外用润滑剂
- 类固醇眼药水
- 非甾体眼药水
- 其他的
根据治疗方法，亚太地区睑裂斑药物市场分为人工泪液/外用润滑剂、类固醇眼药水、非类固醇眼药水和其他。
配方类型
- 眼药水
- 眼药膏
- 其他的
根据配方，亚太地区睑裂斑药物市场分为眼药水、眼药膏和其他药物。
购买方式
- 处方
- 场外交易 (OTC)
根据购买方式，亚太地区睑缘炎药物市场分为处方药和非处方药（OTC）。
药物类型
- 品牌
- 泛型
根据人口类型，亚太地区翼状胬肉药物市场分为品牌药和仿制药。
人口类型
- 老年
- 成年人
根据人口类型，亚太地区睑裂球菌药物市场分为老年人群和成年人群。
最终用户
- 医院
- 专科诊所
- 家庭医疗保健
- 其他的
根据最终用户，亚太地区睑裂木药物市场分为医院、专科诊所、家庭医疗保健和其他。
分销渠道
- 零售药店
- 医院药房
- 网上药店
- 其他的
根据分销渠道，亚太地区松果体药物市场分为零售药店、医院药店、网上药店和其他。
Pingueculum 药物市场区域分析/见解
对亚太地区钉螺药物市场进行了分析，并按国家、药物类型、治疗方法、配方、购买方式、人口类型、最终用户和分销渠道提供了市场规模见解和趋势。
亚太地区翼状胬肉药物市场报告涵盖的国家包括中国、日本、韩国、印度、澳大利亚、新加坡、泰国、马来西亚、印度尼西亚、菲律宾、越南和亚太其他地区。
由于中国出台了减少眼部疾病发病率的举措和计划，预计中国将在亚太地区眼睑板腺药物市场占据主导地位。由于热带地区眼睑板腺发病率不断上升以及老年人口不断增加，预计亚太地区眼睑板腺药物市场将出现增长。
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和市场法规变化。新车和替换车销售、国家人口统计和进出口关税等数据点是预测各个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了亚太品牌的存在和可用性、本土和国内品牌激烈竞争所带来的挑战以及销售渠道的影响。
竞争格局和 Pingueculum 药物市场份额分析
亚太地区 pingueculum 药物市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、亚太地区业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对亚太地区 pingueculum 药物市场的关注有关。
亚太地区睑裂孔药物市场的一些主要参与者包括 Alcon Inc.、Johnson & Johnson Services, Inc.、Novartis AG、Akorn Operating Company LLC、Bausch & Lomb Incorporated、AbbVie Inc.、Prestige Consumer Healthcare Inc.、Spectra Vision Care、Théa Laboratories、Wellona Pharma、SAGER PHARMA、Maya Biotech Private Limited、EYERIS VISIONCARE Pvt. Ltd.、Sylentis、Bayer AG、Zydus Group、Amneal Pharmaceuticals LLC、OASIS Medical、Similasan Corporation、Alcon 和 Santen Pharmaceutical Co., Ltd.
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析以及主要（行业专家）验证。除此之外，数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、亚太地区与地区以及供应商份额分析。如有进一步询问，请要求分析师致电。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们很自豪能够为现有和新客户提供符合其目标的数据和分析。报告可以定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中提供的数据集创建演示文稿。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE ASIA PACIFIC PINGUECULUM DRUGS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 ASIA PACIFIC PINGUECULUM DRUGS MARKET: SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 MULTIVARIATE MODELLING
2.8 TREATMENT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET END-USER COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 EPIDERMIOLOGY
4.2 PESTEL ANALYSIS
4.3 PORTER’S FIVE FORCES
4.4 PIPELINE ANALYSIS FOR THE ASIA PACIFIC PINGUECULUM DRUGS MARKET
4.5 INDUSTRIAL INSIGHTS:
4.6 CONCLUSION:
5 ASIA PACIFIC PINGUECULUM DRUGS MARKET: REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING PREVALENCE OF PINGUECELA DISORDERS AND OCULAR PAINS
6.1.2 RISE IN THE CHRONIC UV RADIATION EXPOSURE DUE TO OZONE DEFECT
6.1.3 INCREASING AWARENESS AMONG PEOPLE FOR EYE-RELATED DISEASES
6.1.4 RISING OPHTHALMIC EMERGENCIES IN THE GERIATRIC PATIENT
6.2 RESTRAINTS
6.2.1 STRINGENT RULES & REGULATIONS
6.2.2 LACK OF HEALTHCARE FACILITIES FOR EYE TREATMENT
6.3 OPPORTUNITIES
6.3.1 INITIATIVES AND PLANS TO LESSEN THE PREVALENCE OF EYE ILLNESSES
6.3.2 INCREASING RESEARCH AND DEVELOPMENT ACTIVITIES
6.3.3 INCREASE IN HEALTHCARE SPENDING AND ACCESSIBLE INCOME
6.4 CHALLENGES
6.4.1 ADVERSE EFFECTS OF STEROID EYE DROPS
6.4.2 LACK OF SKILLED OPHTHALMOLOGISTS
7 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY TREATMENT
7.1 OVERVIEW
7.2 ARTIFICIAL TEARS/TOPICAL LUBRICANTS
7.2.1 DEMULCENT
7.2.2 EMOLLIENTS
7.3 STEROID EYE DROPS
7.3.1 KETONE STEROIDS
7.3.1.1 PREDNISOLONE
7.3.1.2 DEXAMETHASONE
7.3.1.3 FLUROMETHOLONE
7.3.1.4 MEDRYSONE
7.3.1.5 RIMEXOLONE
7.3.1.6 OTHERS
7.3.2 ESTER STEROID (LOTERPREDNOL)
7.4 NON-STEROIDAL ANTI-INFLAMMATORY DROPS
7.5 OTHERS
8 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY FORMULATION
8.1 OVERVIEW
8.2 EYE DROPS
8.2.1 EYE DROPS WITH PRESERVATIVES
8.2.2 PRESERVATIVE-FREE EYE DROPS
8.3 EYE OINTMENTS
8.3.1 WITH PRESERVATIVES
8.3.2 PRESERVATIVE-FREE
8.3.3 OTHERS
8.4 OTHERS
9 ASIA PACIFIC PINGUECULUM DRUGS MARKET, MODE OF PURCHASE
9.1 OVERVIEW
9.2 PRESCRIPTION
9.3 OVER THE COUNTER (OTC)
10 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY DRUGS TYPE
10.1 OVERVIEW
10.2 BRANDED
10.3 GENERICS
11 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY POPULATION TYPE
11.1 OVERVIEW
11.2 GERIATRIC
11.2.1 MALE
11.2.2 FEMALE
11.3 ADULTS
11.3.1 MALE
11.3.2 FEMALE
12 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS
12.3 SPECIALTY CLINICS
12.4 HOME HEALTHCARE
12.5 OTHERS
13 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 RETAIL PHARMACIES
13.3 HOSPITAL PHARMACIES
13.4 ONLINE PHARMACIES
13.5 OTHERS
14 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY REGION
14.1 ASIA-PACIFIC
14.1.1 CHINA
14.1.2 INDIA
14.1.3 JAPAN
14.1.4 INDONESIA
14.1.5 SOUTH KOREA
14.1.6 AUSTRALIA
14.1.7 THAILAND
14.1.8 VIETNAM
14.1.9 PHILIPPINES
14.1.10 MALAYSIA
14.1.11 SINGAPORE
14.1.12 REST OF ASIA- PACIFIC
15 ASIA PACIFIC PINGUECULUM DRUGS MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 ALCON INC.
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 COMPANY SHARE ANALYSIS
17.1.4 PRODUCT PORTFOLIO
17.1.5 RECENT DEVELOPMENT
17.2 ABBVIE INC.
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 COMPANY SHARE ANALYSIS
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENT
17.3 BAUSCH & LOMB INCORPORATED
17.3.1 COMPANY SNAPSHOT
17.3.2 REVENUE ANALYSIS
17.3.3 COMPANY SHARE ANALYSIS
17.3.4 PRODUCT PORTFOLIO
17.3.5 RECENT DEVELOPMENT
17.4 BAYER AG
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 COMPANY SHARE ANALYSIS
17.4.4 PRODUCT PORTFOLIO
17.4.5 RECENT DEVELOPMENTS
17.5 JOHNSON & JOHNSON VISION CARE, INC.
17.5.1 COMPANY SNAPSHOT
17.5.2 REVENUE ANALYSIS
17.5.3 COMPANY SHARE ANALYSIS
17.5.4 PRODUCT PORTFOLIO
17.5.5 RECENT DEVELOPMENT
17.6 AKORN OPERATING COMPANY LLC
17.6.1 COMPANY SNAPSHOT
17.6.2 . PRODUCT PORTFOLIO
17.6.3 RECENT DEVELOPMENT
17.7 AMNEAL PHARMACEUTICALS LLC.
17.7.1 COMPANY SNAPSHOT
17.7.2 REVENUE ANALYSIS
17.7.3 PRODUCT PORTFOLIO
17.7.4 RECENT DEVELOPMENTS
17.8 EYERIS VISIONCARE PVT. LTD.
17.8.1 COMPANY SNAPSHOT
17.8.2 PRODUCT PORTFOLIO
17.8.3 RECENT DEVELOPMENTS
17.9 LABORATOIRES THÉA
17.9.1 COMPANY SNAPSHOT
17.9.2 PRODUCT PORTFOLIO
17.9.3 RECENT DEVELOPMENT
17.1 MAYA BIOTECH PRIVATE LIMITED
17.10.1 COMPANY SNAPSHOT
17.10.2 PRODUCT PORTFOLIO
17.10.3 RECENT DEVELOPMENTS
17.11 NOVARTIS AG
17.11.1 COMPANY SNAPSHOT
17.11.2 REVENUE ANALYSIS
17.11.3 PRODUCT PORTFOLIO
17.11.4 RECENT DEVELOPMENT
17.12 OASIS MEDICAL, INC.
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENT
17.13 PRESTIGE CONSUMER HEALTHCARE, INC.
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENT
17.14 SAGER PHARMA
17.14.1 COMPANY SNAPSHOT
17.14.2 PRODUCT PORTFOLIO
17.14.3 RECENT DEVELOPMENTS
17.15 SANTEN PHARMACEUTICAL CO., LTD.
17.15.1 COMPANY SNAPSHOT
17.15.2 REVENUE ANALYSIS
17.15.3 PRODUCT PORTFOLIO
17.15.4 RECENT DEVELOPMENTS
17.16 SIMILASAN CORPORATION
17.16.1 COMPANY SNAPSHOT
17.16.2 PRODUCT PORTFOLIO
17.16.3 RECENT DEVELOPMENTS
17.17 SPECTRA VISION CARE
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENTS
17.18 SYLENTIS
17.18.1 COMPANY SNAPSHOT
17.18.2 PRODUCT PORTFOLIO
17.18.3 RECENT DEVELOPMENTS
17.19 WELLONA PHARMA
17.19.1 COMPANY SNAPSHOT
17.19.2 PRODUCT PORTFOLIO
17.19.3 RECENT DEVELOPMENTS
17.2 ZYDUS GROUP
17.20.1 COMPANY SNAPSHOT
17.20.2 REVENUE ANALYSIS
17.20.3 PRODUCT PORTFOLIO
17.20.4 RECENT DEVELOPMENTS
18 QUESTIONNAIRE
19 RELATED REPORTS
表格列表
TABLE 1 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 2 ASIA PACIFIC ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 3 ASIA PACIFIC ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 4 ASIA PACIFIC STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 5 ASIA PACIFIC STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 6 ASIA PACIFIC KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 7 ASIA PACIFIC NON-STEROIDAL ANTI-INFLAMMATORY DROPS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 8 ASIA PACIFIC OTHERS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 9 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 10 ASIA PACIFIC EYE DROPS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 11 ASIA PACIFIC EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 12 ASIA PACIFIC EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 13 ASIA PACIFIC EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 14 ASIA PACIFIC OTHERS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 15 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 16 ASIA PACIFIC PRESCRIPTION IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 17 ASIA PACIFIC OVER THE COUNTER (OTC) IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 18 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 19 ASIA PACIFIC BRANDED IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 20 ASIA PACIFIC GENERICS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 22 ASIA PACIFIC GERIATRIC IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 23 ASIA PACIFIC GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 24 ASIA PACIFIC ADULTS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 ASIA PACIFIC ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 26 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 27 ASIA PACIFIC HOSPITALS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 28 ASIA PACIFIC SPECIALTY CLINICS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 29 ASIA PACIFIC HOME HEALTHCARE IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 30 ASIA PACIFIC OTHERS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 31 ASIA PACIFIC PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 32 ASIA PACIFIC RETAIL PHARMACIES IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 33 ASIA PACIFIC HOSPITAL PHARMACIES IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 34 ASIA PACIFIC ONLINE PHARMACIES IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 35 ASIA PACIFIC OTHERS IN PINGUECULUM DRUGS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 36 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 37 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 38 ASIA-PACIFIC ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 39 ASIA-PACIFIC STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 40 ASIA-PACIFIC KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 41 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 42 ASIA-PACIFIC EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 43 ASIA-PACIFIC EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 44 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 45 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 46 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 47 ASIA-PACIFIC GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 48 ASIA-PACIFIC ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 49 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 50 ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 51 CHINA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 52 CHINA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 53 CHINA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 54 CHINA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 55 CHINA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 56 CHINA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 57 CHINA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 58 CHINA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 59 CHINA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 60 CHINA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 61 CHINA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 62 CHINA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 63 CHINA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 64 CHINA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 65 INDIA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 66 INDIA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 67 INDIA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 68 INDIA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 69 INDIA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 70 INDIA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 71 INDIA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 72 INDIA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 73 INDIA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 74 INDIA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 75 INDIA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 76 INDIA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 77 INDIA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 78 INDIA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 79 JAPAN PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 80 JAPAN ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 81 JAPAN STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 82 JAPAN KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 83 JAPAN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 84 JAPAN EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 85 JAPAN EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 86 JAPAN PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 87 JAPAN PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 88 JAPAN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 89 JAPAN GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 90 JAPAN ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 91 JAPAN PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 92 JAPAN PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 93 INDONESIA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 94 INDONESIA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 95 INDONESIA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 96 INDONESIA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 97 INDONESIA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 98 INDONESIA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 99 INDONESIA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 100 INDONESIA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 101 INDONESIA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 102 INDONESIA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 103 INDONESIA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 104 INDONESIA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 105 INDONESIA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 106 INDONESIA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 107 SOUTH KOREA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 108 SOUTH KOREA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 109 SOUTH KOREA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 110 SOUTH KOREA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 111 SOUTH KOREA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 112 SOUTH KOREA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 113 SOUTH KOREA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 114 SOUTH KOREA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 115 SOUTH KOREA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 116 SOUTH KOREA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 117 SOUTH KOREA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 118 SOUTH KOREA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 119 SOUTH KOREA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 120 SOUTH KOREA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 121 AUSTRALIA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 122 AUSTRALIA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 123 AUSTRALIA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 124 AUSTRALIA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 125 AUSTRALIA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 126 AUSTRALIA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 127 AUSTRALIA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 128 AUSTRALIA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 129 AUSTRALIA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 130 AUSTRALIA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 131 AUSTRALIA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 132 AUSTRALIA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 133 AUSTRALIA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 134 AUSTRALIA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 135 THAILAND PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 136 THAILAND ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 137 THAILAND STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 138 THAILAND KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 139 THAILAND PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 140 THAILAND EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 141 THAILAND EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 142 THAILAND PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 143 THAILAND PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 144 THAILAND PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 145 THAILAND GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 146 THAILAND ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 147 THAILAND PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 148 THAILAND PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 149 VIETNAM PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 150 VIETNAM ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 151 VIETNAM STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 152 VIETNAM KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 153 VIETNAM PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 154 VIETNAM EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 155 VIETNAM EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 156 VIETNAM PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 157 VIETNAM PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 158 VIETNAM PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 159 VIETNAM GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 160 VIETNAM ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 161 VIETNAM PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 162 VIETNAM PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 163 PHILIPPINES PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 164 PHILIPPINES ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 165 PHILIPPINES STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 166 PHILIPPINES KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 167 PHILIPPINES PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 168 PHILIPPINES EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 169 PHILIPPINES EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 170 PHILIPPINES PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 171 PHILIPPINES PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 172 PHILIPPINES PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 173 PHILIPPINES GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 174 PHILIPPINES ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 175 PHILIPPINES PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 176 PHILIPPINES PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 177 MALAYSIA PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 178 MALAYSIA ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 179 MALAYSIA STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 180 MALAYSIA KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 181 MALAYSIA PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 182 MALAYSIA EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 183 MALAYSIA EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 184 MALAYSIA PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 185 MALAYSIA PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 186 MALAYSIA PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 187 MALAYSIA GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 188 MALAYSIA ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 189 MALAYSIA PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 190 MALAYSIA PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 191 SINGAPORE PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
TABLE 192 SINGAPORE ARTIFICIAL TEARS/TOPICAL LUBRICANTS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 193 SINGAPORE STEROID EYE DROPS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 194 SINGAPORE KETONE STEROIDS IN PINGUECULUM DRUGS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 195 SINGAPORE PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 196 SINGAPORE EYE DROPS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 197 SINGAPORE EYE OINTMENTS IN PINGUECULUM DRUGS MARKET, BY FORMULATION, 2020-2029 (USD MILLION)
TABLE 198 SINGAPORE PINGUECULUM DRUGS MARKET, BY MODE OF PURCHASE, 2020-2029 (USD MILLION)
TABLE 199 SINGAPORE PINGUECULUM DRUGS MARKET, BY DRUGS TYPE, 2020-2029 (USD MILLION)
TABLE 200 SINGAPORE PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 201 SINGAPORE GERIATRIC IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 202 SINGAPORE ADULTS IN PINGUECULUM DRUGS MARKET, BY POPULATION TYPE, 2020-2029 (USD MILLION)
TABLE 203 SINGAPORE PINGUECULUM DRUGS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 204 SINGAPORE PINGUECULUM DRUGS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 205 REST OF ASIA-PACIFIC PINGUECULUM DRUGS MARKET, BY TREATMENT, 2020-2029 (USD MILLION)
图片列表
FIGURE 1 ASIA PACIFIC PINGUECULUM DRUGS MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC PINGUECULUM DRUGS MARKET: DATA TRIANGULATION
FIGURE 3 ASIA PACIFIC PINGUECULUM DRUGS MARKET: DROC ANALYSIS
FIGURE 4 ASIA PACIFIC PINGUECULUM DRUGS MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA PACIFIC PINGUECULUM DRUGS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA PACIFIC PINGUECULUM DRUGS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA PACIFIC PINGUECULUM DRUGS MARKET: DBMR POSITION GRID
FIGURE 8 ASIA PACIFIC PINGUECULUM DRUGS MARKET: VENDOR SHARE ANALYSIS
FIGURE 9 ASIA PACIFIC PINGUECULUM DRUGS MARKET: END USER COVERAGE GRID
FIGURE 10 ASIA PACIFIC PINGUECULUM DRUGS MARKET: SEGMENTATION
FIGURE 11 INCREASING PREVALENCE OF OPHTHALMIC DISORDERS AND THE RISE IN THE GERIATRIC POPULATION ARE EXPECTED TO DRIVE THE ASIA PACIFIC PINGUECULUM DRUGS MARKET GROWTH FROM 2022 TO 2029
FIGURE 12 ARTIFICIAL TEARS/TOPICAL LUBRICANTS SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE ASIA PACIFIC PINGUECULUM DRUGS MARKET FROM 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC PINGUECULUM DRUGS MARKET
FIGURE 14 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY TREATMENT, 2021
FIGURE 15 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY TREATMENT, 2022-2029 (USD MILLION)
FIGURE 16 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY TREATMENT, CAGR (2022-2029)
FIGURE 17 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY TREATMENT, LIFELINE CURVE
FIGURE 18 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY FORMULATION, 2021
FIGURE 19 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY FORMULATION, 2022-2029 (USD MILLION)
FIGURE 20 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY FORMULATION, CAGR (2022-2029)
FIGURE 21 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY FORMULATION, LIFELINE CURVE
FIGURE 22 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY MODE OF PURCHASE, 2021
FIGURE 23 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY MODE OF PURCHASE, 2022-2029 (USD MILLION)
FIGURE 24 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY MODE OF PURCHASE, CAGR (2022-2029)
FIGURE 25 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY MODE OF PURCHASE, LIFELINE CURVE
FIGURE 26 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY DRUGS TYPE, 2021
FIGURE 27 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY DRUGS TYPE, 2022-2029 (USD MILLION)
FIGURE 28 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY DRUGS TYPE, CAGR (2022-2029)
FIGURE 29 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY DRUGS TYPE, LIFELINE CURVE
FIGURE 30 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY POPULATION TYPE, 2021
FIGURE 31 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY POPULATION TYPE, 2022-2029 (USD MILLION)
FIGURE 32 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY POPULATION TYPE, CAGR (2022-2029)
FIGURE 33 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY POPULATION TYPE, LIFELINE CURVE
FIGURE 34 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY END USER, 2021
FIGURE 35 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY END USER, 2022-2029 (USD MILLION)
FIGURE 36 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY END USER, CAGR (2022-2029)
FIGURE 37 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY END USER, LIFELINE CURVE
FIGURE 38 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 39 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 40 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 41 ASIA PACIFIC PINGUECULUM DRUGS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 42 ASIA-PACIFIC PINGUECULUM DRUGS MARKET: SNAPSHOT (2021)
FIGURE 43 ASIA-PACIFIC PINGUECULUM DRUGS MARKET: BY COUNTRY (2021)
FIGURE 44 ASIA-PACIFIC PINGUECULUM DRUGS MARKET: BY COUNTRY (2022 & 2029)
FIGURE 45 ASIA-PACIFIC PINGUECULUM DRUGS MARKET: BY COUNTRY (2021 & 2029)
FIGURE 46 ASIA-PACIFIC PINGUECULUM DRUGS MARKET: BY TREATMENT (2022-2029)
FIGURE 47 ASIA PACIFIC PINGUECULUM DRUGS MARKET: COMPANY SHARE 2021 (%)
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
